• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干扰素刺激基因 15(ISG15)将皮肌炎肌肉中的蛋白与筋膜旁萎缩相关联。

Interferon-stimulated gene 15 (ISG15) conjugates proteins in dermatomyositis muscle with perifascicular atrophy.

机构信息

Children's Hospital Informatics Program, Division of Neuromuscular Disease, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

出版信息

Ann Neurol. 2010 Jan;67(1):53-63. doi: 10.1002/ana.21805.

DOI:10.1002/ana.21805
PMID:20186858
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2875060/
Abstract

OBJECTIVE

We investigated interferon-stimulated gene 15 (ISG15), a poorly understood ubiquitin-like modifier, and its enzymatic pathway in dermatomyositis (DM), an autoimmune disease primarily involving muscle and skin.

METHODS

We generated microarray data measuring transcript abundance for approximately 18,000 genes in each of 113 human muscle biopsy specimens, and studied biopsy specimens and cultured skeletal muscle using immunohistochemistry, immunoblotting proteomics, real-time quantitative polymerase chain reaction, and laser-capture microdissection.

RESULTS

Transcripts encoding ISG15-conjugation pathway proteins were markedly upregulated in DM with perifascicular atrophy (DM-PFA) muscle (ISG15 339-fold, HERC5 62-fold, and USP18 68-fold) compared with 99 non-DM samples. Combined analysis with publicly available microarray datasets showed that >50-fold ISG15 transcript elevation had 100% sensitivity and specificity for 28 biopsies from adult DM-PFA and juvenile DM patients compared with 199 muscle samples from other muscle diseases. Free ISG15 and ISG15-conjugated proteins were only found on immunoblots from DM-PFA muscle. Cultured human skeletal muscle exposed to type 1 interferons produced similar transcripts and ISG15 protein and conjugates. Laser-capture microdissection followed by proteomic analysis showed deficiency of titin in DM perifascicular atrophic myofibers.

INTERPRETATION

A large-scale microarray study of muscle samples demonstrated that among a diverse group of muscle diseases DM was uniquely associated with upregulation of the ISG15 conjugation pathway. Exposure of human skeletal muscle cell culture to type 1 interferons produced a molecular picture highly similar to that seen in human DM muscle. Perifascicular atrophic myofibers in DM were deficient in a number of skeletal muscle proteins including titin.

摘要

目的

我们研究了干扰素刺激基因 15(ISG15),一种了解甚少的泛素样修饰物,及其在皮肌炎(DM)中的酶促途径,DM 是一种主要累及肌肉和皮肤的自身免疫性疾病。

方法

我们生成了微阵列数据,测量了 113 个人类肌肉活检样本中约 18000 个基因的转录丰度,并使用免疫组织化学、免疫印迹蛋白质组学、实时定量聚合酶链反应和激光捕获显微切割研究了活检样本和培养的骨骼肌。

结果

与 99 个非 DM 样本相比,具有围带萎缩(DM-PFA)的 DM 肌肉中的 ISG15 结合途径蛋白的转录物明显上调(ISG15 上调 339 倍,HERC5 上调 62 倍,USP18 上调 68 倍)。与来自其他肌肉疾病的 199 个肌肉样本相比,与来自成人 DM-PFA 和青少年 DM 患者的 28 个活检样本的结合分析显示,>50 倍的 ISG15 转录物升高对成人 DM-PFA 和青少年 DM 患者的肌肉疾病具有 100%的敏感性和特异性。仅在 DM-PFA 肌肉的免疫印迹中发现游离 ISG15 和 ISG15 结合蛋白。暴露于 1 型干扰素的培养人骨骼肌产生了相似的转录物和 ISG15 蛋白和缀合物。激光捕获显微切割后进行蛋白质组学分析显示,DM 围带萎缩肌纤维中的肌联蛋白缺失。

解释

对肌肉样本进行的大规模微阵列研究表明,在一组不同的肌肉疾病中,DM 是唯一与 ISG15 结合途径上调相关的疾病。将人骨骼肌细胞培养物暴露于 1 型干扰素可产生与人 DM 肌肉非常相似的分子图像。DM 中的围带萎缩肌纤维缺乏许多骨骼肌蛋白,包括肌联蛋白。

相似文献

1
Interferon-stimulated gene 15 (ISG15) conjugates proteins in dermatomyositis muscle with perifascicular atrophy.干扰素刺激基因 15(ISG15)将皮肌炎肌肉中的蛋白与筋膜旁萎缩相关联。
Ann Neurol. 2010 Jan;67(1):53-63. doi: 10.1002/ana.21805.
2
From Diagnosis to Prognosis: Revisiting the Meaning of Muscle ISG15 Overexpression in Juvenile Inflammatory Myopathies.从诊断到预后:重新审视肌内 ISG15 过表达在青少年特发性炎性肌病中的意义。
Arthritis Rheumatol. 2021 Jun;73(6):1044-1052. doi: 10.1002/art.41625. Epub 2021 Apr 26.
3
Muscle Expression of Type I and Type II Interferons Is Increased in Juvenile Dermatomyositis and Related to Clinical and Histologic Features.Ⅰ型和Ⅱ型干扰素在幼年皮肌炎中的肌肉表达增加,并与临床和组织学特征相关。
Arthritis Rheumatol. 2019 Jun;71(6):1011-1021. doi: 10.1002/art.40800. Epub 2019 Apr 30.
4
RIG-I expression in perifascicular myofibers is a reliable biomarker of dermatomyositis.束周肌纤维中的视黄酸诱导基因I(RIG-I)表达是皮肌炎的可靠生物标志物。
Arthritis Res Ther. 2017 Jul 24;19(1):174. doi: 10.1186/s13075-017-1383-0.
5
Identification and validation of interferon-stimulated gene 15 as a biomarker for dermatomyositis by integrated bioinformatics analysis and machine learning.通过整合生物信息学分析和机器学习鉴定和验证干扰素刺激基因 15 作为皮肌炎的生物标志物。
Front Immunol. 2024 Nov 4;15:1429817. doi: 10.3389/fimmu.2024.1429817. eCollection 2024.
6
Differential roles of hypoxia and innate immunity in juvenile and adult dermatomyositis.缺氧和固有免疫在青少年和成人皮肌炎中的差异作用。
Acta Neuropathol Commun. 2016 Apr 27;4(1):45. doi: 10.1186/s40478-016-0308-5.
7
Dermatomyositis and type 1 interferons.皮肌炎与 1 型干扰素。
Curr Rheumatol Rep. 2010 Jun;12(3):198-203. doi: 10.1007/s11926-010-0101-6.
8
Class I MHC detection as a diagnostic tool in noninformative muscle biopsies of patients suffering from dermatomyositis (DM).I类主要组织相容性复合体检测作为皮肌炎(DM)患者非诊断性肌肉活检的诊断工具。
Neuropathol Appl Neurobiol. 2003 Dec;29(6):546-52. doi: 10.1046/j.1365-2990.2003.00471.x.
9
Immunoproteasome subunit β5i promotes perifascicular muscle atrophy in dermatomyositis by upregulating RIG-I.免疫蛋白酶体亚基 β5i 通过上调 RIG-I 促进皮肌炎的筋膜旁肌萎缩。
RMD Open. 2023 Feb;9(1). doi: 10.1136/rmdopen-2022-002818.
10
Type 1 interferons inhibit myotube formation independently of upregulation of interferon-stimulated gene 15.1型干扰素独立于干扰素刺激基因15的上调来抑制肌管形成。
PLoS One. 2013 Jun 4;8(6):e65362. doi: 10.1371/journal.pone.0065362. Print 2013.

引用本文的文献

1
The complement system in autoimmune diseases: pathogenesis, diagnostic markers, and therapeutic strategies.自身免疫性疾病中的补体系统:发病机制、诊断标志物及治疗策略。
Inflamm Res. 2025 Jun 30;74(1):93. doi: 10.1007/s00011-025-02061-0.
2
Immune Characterization of a Vietnamese Cohort With Idiopathic Inflammatory Myopathies.越南特发性炎性肌病队列的免疫特征分析
Muscle Nerve. 2025 Sep;72(3):464-474. doi: 10.1002/mus.28455. Epub 2025 Jun 16.
3
Distinct Cytokine and Cytokine Receptor Expression Patterns Characterize Different Forms of Myositis.不同的细胞因子和细胞因子受体表达模式可区分不同形式的肌炎。
medRxiv. 2025 Feb 21:2025.02.17.25321047. doi: 10.1101/2025.02.17.25321047.
4
Ultrasensitive interferons quantification reveals different cytokine profile secretion in inflammatory myopathies and can serve as biomarkers of activity in dermatomyositis.超敏干扰素定量分析揭示了炎性肌病中不同的细胞因子分泌谱,并且可作为皮肌炎活动的生物标志物。
Front Immunol. 2025 Feb 12;16:1529582. doi: 10.3389/fimmu.2025.1529582. eCollection 2025.
5
UBXN9 governs GLUT4-mediated spatial confinement of RIG-I-like receptors and signaling.UBXN9 调控 GLUT4 介导的 RIG-I 样受体的空间局限及其信号转导。
Nat Immunol. 2024 Dec;25(12):2234-2246. doi: 10.1038/s41590-024-02004-7. Epub 2024 Nov 20.
6
Type I interferon biomarker in idiopathic inflammatory myopathies: associations of Siglec-1 with disease activity and treatment response.特发性炎性肌病中的I型干扰素生物标志物:唾液酸结合免疫球蛋白样凝集素-1与疾病活动度及治疗反应的关联
Rheumatology (Oxford). 2025 May 1;64(5):2979-2986. doi: 10.1093/rheumatology/keae630.
7
Identification and validation of interferon-stimulated gene 15 as a biomarker for dermatomyositis by integrated bioinformatics analysis and machine learning.通过整合生物信息学分析和机器学习鉴定和验证干扰素刺激基因 15 作为皮肌炎的生物标志物。
Front Immunol. 2024 Nov 4;15:1429817. doi: 10.3389/fimmu.2024.1429817. eCollection 2024.
8
Clinico-sero-pathological profiles and risk prediction model of idiopathic inflammatory myopathy (IIM) patients with different perifascicular changes.特发性炎性肌病(IIM)患者不同束周改变的临床-血清-病理特征及风险预测模型。
CNS Neurosci Ther. 2024 Aug;30(8):e14882. doi: 10.1111/cns.14882.
9
Pathological autoantibody internalisation in myositis.肌炎中的病理性自身抗体内化。
Ann Rheum Dis. 2024 Oct 21;83(11):1549-1560. doi: 10.1136/ard-2024-225773.
10
UBXN9 governs GLUT4-mediated spatial confinement of RIG-I-like receptors and signaling.UBXN9调控RIG-I样受体的GLUT4介导的空间限制及信号传导。
Res Sq. 2024 Jun 4:rs.3.rs-3373803. doi: 10.21203/rs.3.rs-3373803/v1.

本文引用的文献

1
Development of Potential Pharmacodynamic and Diagnostic Markers for Anti-IFN-α Monoclonal Antibody Trials in Systemic Lupus Erythematosus.系统性红斑狼疮抗干扰素-α单克隆抗体试验潜在药效学和诊断标志物的开发
Hum Genomics Proteomics. 2009 Nov 17;2009:374312. doi: 10.4061/2009/374312.
2
Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus.在系统性红斑狼疮患者中进行的一项抗干扰素-α单克隆抗体I期试验中,干扰素-α/β诱导基因的中和作用及下游效应
Arthritis Rheum. 2009 Jun;60(6):1785-96. doi: 10.1002/art.24557.
3
Characterization of human skeletal muscle biopsy samples using shotgun proteomics.使用鸟枪法蛋白质组学对人骨骼肌活检样本进行表征分析。
J Proteome Res. 2009 Jul;8(7):3265-77. doi: 10.1021/pr800873q.
4
Fast-twitch sarcomeric and glycolytic enzyme protein loss in inclusion body myositis.包涵体肌炎中快肌肌节和糖酵解酶蛋白的丢失
Muscle Nerve. 2009 Jun;39(6):739-53. doi: 10.1002/mus.21230.
5
Similar topology of injury to keratinocytes and myofibres in dermatomyositis skin and muscle.
Br J Dermatol. 2009 Feb;160(2):464-5. doi: 10.1111/j.1365-2133.2008.08967.x. Epub 2008 Dec 10.
6
Duration of chronic inflammation alters gene expression in muscle from untreated girls with juvenile dermatomyositis.慢性炎症的持续时间会改变未经治疗的青少年皮肌炎女孩肌肉中的基因表达。
BMC Immunol. 2008 Jul 31;9:43. doi: 10.1186/1471-2172-9-43.
7
Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis.血液中I型干扰素诱导基因表达存在,且反映皮肌炎和多肌炎的疾病活动情况。
Arthritis Rheum. 2007 Nov;56(11):3784-92. doi: 10.1002/art.22928.
8
Proposed immunologic models of the inflammatory myopathies and potential therapeutic implications.炎性肌病的免疫模型及潜在治疗意义
Neurology. 2007 Nov 20;69(21):2008-19. doi: 10.1212/01.WNL.0000291619.17160.b8. Epub 2007 Oct 10.
9
HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type I IFN-induced ISGylation of protein targets.HERC5是一种干扰素诱导的HECT型E3蛋白连接酶,它介导I型干扰素诱导的蛋白质靶点ISGylation。
Proc Natl Acad Sci U S A. 2006 Jul 11;103(28):10735-40. doi: 10.1073/pnas.0600397103. Epub 2006 Jun 30.
10
Type I interferon-associated skin recruitment of CXCR3+ lymphocytes in dermatomyositis.皮肌炎中I型干扰素相关的CXCR3 +淋巴细胞向皮肤的募集
Clin Exp Dermatol. 2006 Jul;31(4):576-82. doi: 10.1111/j.1365-2230.2006.02150.x.